Murdoch loses $100 million on Theranos investment
Australian-American media mogul Rupert Murdoch, chairman and CEO of global media holding company News Corporation, is expected to lose the $100 million he invested in beleaguered blood testing group Theranos.
Murdoch, who purchased his stake when Theranos’ valuation was at the $9 billion mark, is likely to notice the irony after his own financial paper, The Wall Street Journal, played an instrumental role in questioning the reliability of its blood testing device.